Tag Archives: NASDAQ:CLBS

Analysts Offer Insights on Services Companies: Caladrius Biosciences (NASDAQ: CLBS) and Zillow Group Inc (NASDAQ: ZG)

Companies in the Services sector have received a lot of coverage today as analysts weigh in on Caladrius Biosciences (CLBS – Research Report) and Zillow Group Inc (ZG – Research Report). Caladrius Biosciences (CLBS) Chardan Capital analyst Keay Nakae reiterated

H.C. Wainwright Reaffirms Their Buy Rating on Caladrius Biosciences (CLBS)

H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on Caladrius Biosciences (CLBS – Research Report) today and set a price target of $18.50. The company’s shares opened today at $4.55. Pantginis noted: “Valuation and risks to price target achievement;

H.C. Wainwright Remains a Buy on Caladrius Biosciences

H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Caladrius Biosciences (NASDAQ: CLBS) today and set a price target of $12. The company’s shares opened today at $4.26. According to TipRanks.com, Selvaraju is ranked 0 out of 5 stars

H.C. Wainwright Reiterates Their Buy Rating on Caladrius Biosciences

In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on Caladrius Biosciences (NASDAQ: CLBS), with a price target of $12. The company’s shares closed yesterday at $5.75. According to TipRanks.com, Selvaraju is ranked 0 out

H.C. Wainwright Thinks Caladrius Biosciences’ Stock is Going to Recover

H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Caladrius Biosciences (NASDAQ: CLBS) today and set a price target of $7. The company’s shares closed yesterday at $3.13, close to its 52-week low of $2.63. According to TipRanks.com, Selvaraju

Caladrius Biosciences Gets a Buy Rating from H.C. Wainwright

In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on Caladrius Biosciences (NASDAQ: CLBS), with a price target of $7. The company’s shares closed yesterday at $4.06. According to TipRanks.com, Selvaraju is ranked 0 out